Literature DB >> 3768768

Anaphylactoid reaction to atracurium.

J E Tetzlaff, M D Gellman.   

Abstract

Atracurium is a new intermediate-acting muscle relaxant, relatively devoid of cardiovascular effect in the clinical dose range. Histamine release is reported in a dose-dependent fashion, but below the threshold for haemodynamic effect within the recommended dose limits. We report a case of an anaphylactoid reaction to a low dose (0.2 mg X kg-1) of atracurium, and discuss the peculiar aspects of this case that predisposed the patient to this event.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3768768     DOI: 10.1007/bf03014271

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  20 in total

1.  Probable histamine liberation with atracurium. A case report.

Authors:  G G Lavery; M M Boyle; R K Mirakhur
Journal:  Br J Anaesth       Date:  1985-08       Impact factor: 9.166

2.  Cardiovascular effects of pancuronium in man.

Authors:  G R Kelman; B R Kennedy
Journal:  Br J Anaesth       Date:  1971-04       Impact factor: 9.166

Review 3.  Systemic anaphylaxis in the human being.

Authors:  K F Austen
Journal:  N Engl J Med       Date:  1974-09-26       Impact factor: 91.245

4.  Histamine release following pancuronium. A case report.

Authors:  R W Buckland; A F Avery
Journal:  Br J Anaesth       Date:  1973-05       Impact factor: 9.166

5.  Bronchospasm in an asthmatic patient following pancuronium.

Authors:  M L Heath
Journal:  Anaesthesia       Date:  1973-07       Impact factor: 6.955

6.  Cardiovascular effects of alcuronium in man.

Authors:  B R Kennedy; G R Kelman
Journal:  Br J Anaesth       Date:  1970-07       Impact factor: 9.166

7.  Atracurium in normal doses may release histamine.

Authors:  M A Fox
Journal:  Anesthesiology       Date:  1984-04       Impact factor: 7.892

8.  Haemodynamic effects of bolus injections of atracurium in patients with coronary artery disease.

Authors:  D M Philbin; V R Machaj; R C Tomichek; R C Schneider; J C Alban; E Lowenstein; C C Lineberry
Journal:  Br J Anaesth       Date:  1983       Impact factor: 9.166

9.  The cardiovascular effects of vecuronium (ORG NC45) and pancuronium in patients undergoing coronary artery bypass grafting.

Authors:  R B Morris; M K Cahalan; R D Miller; P L Wilkinson; A L Quasha; S L Robinson
Journal:  Anesthesiology       Date:  1983-05       Impact factor: 7.892

Review 10.  Adverse effects of intravenously administered drugs used in anaesthetic practice.

Authors:  R S Clarke
Journal:  Drugs       Date:  1981-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.